Dataset Information

N6-methyladenosine circRNA Epitranscriptomic Microarray analysis in peripheral blood of patients with β-thalassemia intermedia and major_10 samples

ABSTRACT: β-thalassemia is a group of bone marrow disorders characterized by defects in erythropoiesis. Circular RNAs (circRNAs) are functionally significant and hold tremendous potential as diagnostic biomarkers and therapeutic targets in numerous human diseases. Although the functional interplay between N6-methyladenosine (m6A) RNA modifications and circRNAs is becoming increasingly well understood, their specific cross-talk in β-thalassemia remains poorly characterized. Here, we aim to identify the differentially expressed m6A circRNAs in β-thalassemia and elucidate the function of m6A modification and the mechanism by which circRNAs regulate erythropoiesis.

ORGANISM(S): Homo sapiens

PROVIDER: GSE336966 | GEO | 2026/07/10

REPOSITORIES: GEO

ACCESS DATA

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Project description:Background: The thalassemias are highly diverse at both the molecular and clinical levels. Many of the HBB mutations that result in β-thalassemia are missense mutations in the coding region of the β-globin gene, but a few cause alternative splicing, and interfere with normal processing of the β-globin transcripts. Transcriptome profiling in individuals affected with β-thalassemia, especially in individuals who carry novel mutations in the HBB, may improve our understanding of the heterogeneity and molecular mechanisms of the disease. Methods: Members of a family with a daughter affected with thalassemia intermedia, although her mother was not clinically affected, were examined for physical characteristics, hematological parameters and β-globin gene sequences. We also characterized genome-wide gene expression in the family using RT-qPCR and high-throughput RNA-sequencing mRNA expression profiling of blood. Results: Clinical findings, hematological indices, DNA and RNA sequence analysis of individuals with β-thalassemia, including the description of a novel mutation in the β-globin gene, which introduces a cryptic donor splice site. More than 300 genes are differentially expressed in β-thalassemic blood with many of the DEGs involved in pathways relevant to the clinical management of β-thalassemia. β-thalassemia shows important similarities and differences with sickle cell disease at the transcriptome level. Conclusions: We described the down-regulation of the β-globin gene in β-thalassemia by RNA-sequencing analysis using a sample from an affected individual and her mother, who have a novel mutation in the HBB that creates a cryptic donor splice site. The daughter has a typical β-thalassemia allele as well, and an unexpectedly severe phenotype. The DEGs are enriched in pathways that are directly or indirectly related to β-thalassemia such as hemopoiesis, heme biosynthesis, response to oxidative stress, inflammatory responses, immune responses, control of circadian rhythm, apoptosis, and other cellular activities. We compare our findings with published results of RNA-Sequencing analysis of sickle cell disease (SCD) and erythroblasts from a KLF1-null neonate with hydrops fetalis, and recognize similarities and differences in their transcriptional expression patterns.

Dataset Information

N6-methyladenosine circRNA Epitranscriptomic Microarray analysis in peripheral blood of patients with β-thalassemia intermedia and major_10 samples

Dataset's files

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets